Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1611 1612 1613 1617 1621 1627 1629
This examiner grants 32% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18546258 | TREATMENT OF MYOPIA | Non-Final OA | University of Utah Research Foundation |
| 18400940 | PEROXYMONOSULFATE ORAL WHITENING COMPOSITIONS | Non-Final OA | Colgate-Palmolive Company |
| 17908506 | ADJUVANT-ANTIBIOTIC COMBINATION AGAINST GRAM-NEGATIVE BACTERIA | Final Rejection | University of Notre Dame du Lac |
| 18518772 | COMPOSITION FOR IMPROVING OR PREVENTING IRON DEFICIENCY ANAEMIA | Non-Final OA | AJINOMOTO CO., INC. |
| 17792282 | PHARMACEUTICAL COMPOSITION OF TRICYCLIC PDE3/PDE4 DUAL INHIBITOR COMPOUND | Non-Final OA | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. |
| 17119000 | USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO TREAT DYSFUNCTIONAL TEAR SYNDROME (DTS) | Final Rejection | MESHABERASE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy